Stats

Reused,notrerun,recorded1720/1682MonteCarlo with1685Kellyunitcorrection. NumPyseed2026090908,50000bootstrap paths of10selectedtimeonlyeventreturns.25%capital hypotheticalmeanterminal51.17792 from49.14,5/50/95quantiles47.38995/50.79397/56.33595,lossprob25.418%. Thoseare10events,not10sessions orremainingmonth opportunities; sampleN10concentratedandrequiredcoststressedexitsnegative. NewSep9LOVEpaperoutcomeunfinished so cannotupdateempiricaldistribution. Favorableconditionalmean isstrongestcounterargumenttocash, butsimulationaddsnopopulationdata orvenueexitvalidation; adoptedallocation0,terminalcash49.14beforeexternalcosts. No liveprofitoddsclaimed. Sources https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all ; prioranalyses1682/1685/1720.

1. Read original backtests38,1677/78,1688 andqueriedownledger. CHWY chronologicalholdoutN6 p=.5 W=.04523391 L=.04828695,return-1.719988%,DD14.258614%; PythonquarterKellycapital(p/L-(1-p)/W)/4=-.1747224,clipped0. Prospective pre-event N1 -2.687668%remainsseparate. 2. LOVE1677N10 basep30%,W7.292817%,L2.929065%,return-.368512%,DD12.286896%; stressp20%,W10.702374%,L2.753813%,return-2.341352%,mean-.062576%,CI[-3.319283,4.058455]%. Selectedtimeonlygaincannotvalidate requiredexits; all CIs cross0.3. Own0/3wins,meanloss16.380601%,avgwinnerundefined,2operatorliquidations censorhorizon. Strongestcounterexample smallsamplecannotproveallfutureedgesnegative; conclusioniszerojustifiedallocationtoday,notuniversalinefficacy. No rerun of identical rejected backtests or parameter selection fromtoday'sgap. ExistingCLI58/1688diagnosticlimits retained. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; runway:query_trades?fund=catalyst ; originaldates inanalysis38observations84–101.

1. Sep9 delayed SIP firstminute CHWYopen21.85 vs23.27close=-6.1023%;13:36C21.32=-8.3799%. SPYopen764.08vs765.96=-.2454%, does not explain all company decline; not causal attribution. Prior20SIP CHWYSMA23.378/ADR.91168, LOVE16.47025/.655065, SPY768.6995/4.46606. 2.09:50IEXminuteC21.59 distinct from13:52:36IEXbid21.67ask21.70, exactcurrentSIPNBBO403. LOVEIEXtrade staleSep8 andwidequote cannot size exits. 3. LOVEpaper frozen1677 Sep9open15.87→stop15.214935,target16.8525975,timeexit19:45UTC; observe15minclose thennextopen, fee/slip retained. No completed paperoutcome beforetime. Rebound is counterexample to assumingnegativegap meansfurtherloss; no tested drift rule. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=CHWY,LOVE,SPY&timeframe=1Min&feed=sip&adjustment=all . Observations18520–23 preserve fullcalculation/input timestamps. These are bars, notfills; remainzero.

1. Direct issuer SEC Sep9 Q2 endedAug2 reports organic growth5.7%,total7.3%,EBITDA6.8%; OCF137.4m versus133.9,FCF89.5 versus105.9. 2. Python cash bridge +3.5m OCF minus19.9m incrementalcapex gives -16.4mFCF (-15.4863%). Therefore FCF deterioration does not prove demand or collections deteriorated; higher investment is the immediate explanation. 3. Syndicated issuer presentation PUBT gives FY13.46–13.57bn and6.7–6.8%margin,Q3sales3.323–3.358bn and6.6–6.7%margin. Exact original/priorguide/call unavailable, so magnitude of raise unverified; do not claim organic acceleration from acquisitions. Strongest counterargument investment delivers high future returns and rising operatingcashsupports it; next evidence needs clinic/pharmacy economics and retainedcash. Conclusion watch fundamentals, no price payoff or valuation established. One company origin across SEC and syndication. Sources https://www.sec.gov/Archives/edgar/data/1766502/000162828026061011/chwyq22026exhibit991.htm ; https://www.marketscreener.com/news/chewy-second-quarter-2026-earnings-presentation-ce785bd9dc8df026 ; primary IR blocked https://investor.chewy.com/financials/quarterly-results/default.aspx .

Start49.14fundcash,850.99equity,zeroownholdings/queuedorders perqueriedledger; goalrepeatablepre-eventgains. Bindingconstraint independent net actual-windowedge, not349.01monthlyshortfall. Premise1 readnotes/lessons513–515 andfrozen38/1677/1688/1682with1685Kellycorrection:CHWYholdout-1.72%N6;LOVErequiredexits-.3685%N10/stress-2.3414%,allmeanCIsinclude0. Premise2 now8issuercompletedreleases1710–17 give mixedcashandimprovingoperations; favorableBRZEcashandGMEguidance are strongestcounterarguments, butposteventstrategyunvalidatedandpre-eventwindowelapsed. Premise3 prospectiveCHWYpaper-2.687668%N1 (18490/1718) doesnot rehabilitaterule. Premise4 technical1719/reusedsimulation1720 cannot manufacturepositiveentryedge. Conclusion allocations0andnoproposals: no order/stop/targetneedsmaintenance; no newbacktestneeded torepeatfrozenrejections. Validity: absentrequiredvalidatededge, mandatedsize0follows. Soundnesslimitedbysmallselectedsamples, feed/timezoneinconsistency, firstnewsminuteunknown, nofullcurrentbidask andunreadcalls; nonepermitspositiveallocation. Evidencewouldmoveaction: independentlypreregisteredcostedwindow/venuecadenceholdoutwithcrediblepositiveexpectancyplusfreshquotesanddocumentedpre-eventexit. QuarterKellycapitalformula(p/L-(1-p)/W)/4,thenuncertainty/fund49.14/position212.7475/risk8.5099caps; currentunknownorfailededge->0. Review12/15/17/18/32/126resolved;135CHWY13:50,136ASO/KFY16:30,137LOVEtomorrowarmed;futureFDAmonitorspreserved. Collector118truncated2000chars replacedafter1803bytecomplete11paneltest by138, actualfirstsandboxpending;132actualfullfooterverified. Gaps: exactCHWYguide,ASOrefund10Q,KFYcash/AMS,GME37.7marknetting,organicBRZE/SAIL/CNMbridges; AVO/PPIHoverflowfollowupsnotcompletedthisboundedtradingreview. Full URLs in1710–21 andobservations. RawfundamentalprimarydatesSep8/9; no guessingcalendar. Sources: https://www.sec.gov/Archives/edgar/data/1766502/000162828026061018/chwy-20260802.htm ; https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all .

Premises primaryfundamentals1710–17 showdemandgrowthcoexistingwith cash/financingconstraints. Firstorder: Chewy/SailPoint acquisitions andsoftware/capex consume cash despite customer/ARRgrowth; Academyper-shareprofits benefit fromlowerdenominator; Caseyfuelmargincapturesmoregrossprofitthaninsideincrement. Secondorder (inference): suppliers, acquiredowners, employeesreceivingequity andrepurchasingstockholders can capturecash ahead ofremainingowners; CNMpayablesfinanceinventorywhilecustomersdefercash, KFYAMSguidanceaddsacquiredscale. Thirdorder (conditional): sustained investmentcashreturnswouldimproverecurringper-sharevalue; slowcollections/dilution/costnormalizationwouldshiftneedtoward externalfundingandreducepricepayoff. Strongestcounterargument theseinvestmentsmayproducehighfutureROIC; currentlymeasuredquartercashdoesnotsettleit. No competitortradeorFUNDproposalbecauseindependentstockpayoffunknown. Source-origin eightissuers, releasesandtheirSECcopiesareoneoriginapiece: https://www.sec.gov/Archives/edgar/data/1766502/000162828026061018/chwy-20260802.htm ; https://www.sec.gov/Archives/edgar/data/1817358/000181735826000146/exhibit991pressreleaseq220.htm ; https://investor.sailpoint.com/static-files/b83fe64e-3bb0-41aa-aa9a-acf0940242e4 ; https://www.sec.gov/Archives/edgar/data/1856525/000185652526000091/cnmq22026earningspressrele.htm ; https://ir.kornferry.com/news-events/press-releases/detail/733/korn-ferry-announces-first-quarter-fiscal-2027-results-of-operations ; https://www.sec.gov/Archives/edgar/data/1676238/000167623826000039/a20260731-brazeincxq227ear.htm ; https://news.gamestop.com/news-releases/news-details/2026/GameStop-Discloses-Second-Quarter-2026-Results/default.aspx ; https://investor.caseys.com/news-releases/news-release-details/caseys-announces-first-quarter-results-3

No new simulation or invented live forecast. Read1682:NumPyseed2026090908,50000resamplesof10empiricaltime-onlyreturns over10hypotheticalevents; 25%capitaldeploymentmeanterminal51.17792from49.14,5/50/95quantiles47.38995/50.79397/56.33595,lossprobability25.418%. Fullcapitalmean57.63877/loss26.782%; constantcash49.14. 1. These eventsarenot10days oravailablemonth-endopportunities. 2. SelectedN10time-onlydistribution dominatedbyonebroadmarketday; mandatoryexitcoststressnegative, pathsaddnopopulationinformation. 3. Analysis1685 andlesson514 supersede1682paragraph3cash-Kellyinterpretation; use(p/L-(1-p)/W)/4 forcapital. Conclusion favorableconditionalmeanisanexplicitcounterargumenttocashbutunsupportedforactualwindow, adoptedfraction0. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all ; prior1682/1685. No need togenerateanother50000paths fromsameunstableinput.

1. Sep8IEXCHWY23.27belowSMA20 23.3815;LOVE16.12below16.4585;SPY766.06below768.6585. ADR20 respectively.874/.42425/4.407. Completed prior-session context only, no freshbidask. 2. LOVEpreviousSIPclose16.07/ADR.655065 differs from IEX: cannotreplace feed-specific range with smallerstop andclaim1677validation. 3. Fixed mandatoryexitLOVE1677N10 -.3685%base/-2.3414%stress,meanCIcrosseszero; CLI1688N56 -17.85%no-feeunsplit diagnostic alsofailed. No newbacktest rerun because no changedeligibleedge; currenttechnicalstatescannotrepairnegativecoststress oruncertainty. Conclusion noentry/stop/targetproposal. Strongestcounterexample dipbelowSMAcouldprecederebound; independentlytestthatnewrulebeforetrust. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=CHWY,LOVE,SPY&timeframe=1Day&feed=iex&adjustment=all ; SIPtest https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all .

1. Queried Catalyst ledger contains3closedlosses,0open/pending/closing,2operatorliquidations censor intendedhorizons. Pythonreturns MIRM-.439321%,IONS-2.842420%,RARE-45.860062%;meanloss16.380601%,winrate0/3,avgwinnerundefined. No positive edge estimate from ledger; sample too small toprove allfutureedgesnegative. RAREexit13.98976 vsstop24 =41.7093%worse, gapnotboundedbylogicalstop. 2. Separate frozenCHWY38 prospective N1 paper: Aug25IEXopen24.47 toSep8open23.86,5bpfee/slip eachside net-2.687668%; negative newobservation, not appendedtohistoricalholdout toretuneparameters. OriginalhistoricalN6p50%,W4.523391%,L4.828695%,mean-.152652%,return-1.719988%,DD14.258614% retained. 3. Costs andcorrectedcapitalKelly(p/L-(1-p)/W)/4 implynonpositiveCHWYcapital; adopted0. Sources runway:query_trades?fund=catalyst ; https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=CHWY,LOVE,SPY&timeframe=1Day&feed=iex&adjustment=all . No fabricatedavgwinner or pricededge.

1. Q1EBITDA+17.1%,insidecomps+3.2%,margin42.2%improve. 2. Fuelmargin47.8cvs41.0c,same-storegallons-.3%; fuelaccounts62.33%incrementalcombinedinside+fuelgrossprofit,so earningsgrowthnotjustcustomervolume. 3. OCF384.072m+3.13%,capex194.395m vs110.046; cashaftercapex189.677m falls27.71%before43.904macquisitions; FCFproxydefinedexplicitly. FYEBITDAgrowth8–10%unchanged despitequarterstrength. Conclusion operationallypositivebutfuelmargins/capexpayoutwindowcanlimitnear-termcash; no independentlyvalidatedpriceedge. Strongestcounterargument investmentscreatefuturestorecashandfuelmarginmaybe durable; requirenewstorepaybackandnetactualwindowtest. No whole-shareaffordabilityclaimfromstaleprice. Primary https://investor.caseys.com/news-releases/news-release-details/caseys-announces-first-quarter-results-3

Sep9 premarket review; issuer-source facts separated from derived arithmetic and inference. 1. Actualsales790.2m,operatingincome160.2m,net298.7m allwithinAug31prelimranges; largeYoYoperatinggainwasalreadydisclosed. 2. >650mEBITDAguide versus>600m isnewexpectation (+8.33%floor), collectibles356.3m/45.1%mixsupportsoperatingshift. 3. Q2FCF60.7m falls46.43%vsH1FCF+29.94%: differentperiodsreconcilecashnarratives. Investmentgains/digitalassetmarksarenotoperatingincomeorverifiedspotflows; releasecashflowderivative203.6+equity72.1 differsfromprelim~238net,37.7gapneedsfullfilingdefinitions. Conclusion favorableguidance butcurrentpre-eventwindowwascontaminatedAug31; no run-upreentry. Strongestcounterargument collectiblesmixandsavingssupportrecurringprofit; requirecashconversionandindependenttestedstockedge. Do not countpressreleasecopiesasindependentconfirmation. Primary: https://news.gamestop.com/news-releases/news-details/2026/GameStop-Discloses-Second-Quarter-2026-Results/default.aspx

Sep9 premarket review; issuer-source facts separated from derived arithmetic and inference. 1. Revenue227.2m exceeds219.5–220.5guide; subscriptiongrowth20.90% trails total26.2%, services+136.14% changesmix. Organicdefinitionprovided butnonnumericacquisitionbridgeremainsgap. 2. GAAPGM66.8vs67.7%,NRR110vs108%; GAAPoploss18.1m improves,adjustedop22m. 3. FCF21.744m vs3.533improves substantially aftercapex/software; SBC35.661m stilllarger, FCFlessSBC-13.917m economicproxy. Conclusion bettercashandretention are crediblefutureevidence, not validatedpost-earningsdrift. Counterexample investedservices mayhelp futureSaaSretentionratherthanlowqualitysales; requireorganicmix/costandfuturecohortanalysis. FYrevenue910–913m/adjustedEPS.64–.65; nointrinsicvaluationortradetargetestablished. Primary: https://www.sec.gov/Archives/edgar/data/1676238/000167623826000039/a20260731-brazeincxq227ear.htm

Sep9 premarket review; issuer-source facts separated from derived arithmetic and inference. 1. Q1feerevenue756.5m+7%actual/constantcurrency,bookings832.3m andremaining1915mimprove. 2. EBITDAmargin17%flat, GAAPmargin9.1vs9.4%; growthnotmarginexpansion. 3. Q2guide860–878mincludesAMSSept/Oct afterSep1close, so jumpcannotbecalledorganic. Releasehasno cashflowstatement andsubmissionfeednoQ110Qyet: cashaftercapex/SBCunknown, notzero. Conclusion prospectivebusinessimprovementbutno executablepre-eventwindow/independentposteventedge. Counterargument crosssellingAMSraisesfuturereturns; requires financedpurchaseprice, incrementalearningsandcashbridge. NoonETcallpending; successorwillcheckfullresults/filing. No purchase. Primary: https://ir.kornferry.com/news-events/press-releases/detail/733/korn-ferry-announces-first-quarter-fiscal-2027-results-of-operations

Sep9 premarket review; issuer-source facts separated from derived arithmetic and inference. 1. Q2sales2145m+2.5%,EBITDA274m+3%,GM26.7vs26.8%; municipal/fire/datacenterstrength ismanagementattribution, exactorganicgrowthunreported. 2. H1sales+1.3%primarilyacquisitions, EBITDA500m, OCF144m:28.8%conversion versusFYguide60–70%. 3. Reaffirmed950–980mEBITDAimpliesFYOCF570–686m andH2need426–542m; this is guide arithmetic, not forecast. H1FCFproxy112m beforeTRA42m andbuybacks257m; payablecashsource301vs196m helpscash. Conclusion underlyinggrowthpositivebutcashseasonality/unwindremainsbinding; no run-upentry afternews. Strongestcounterargument seasonallystrongH2collections canachieveguide; would need historicalseasonaldistribution andactualcollections beforerejectingguide. No new valuation or validatedeventedge. Primary: https://www.sec.gov/Archives/edgar/data/1856525/000185652526000091/cnmq22026earningspressrele.htm

Sep9 premarket review; issuer-source facts separated from derived arithmetic and inference. 1. ARR1231m+25%,SaaS847m+36%,RPO1.9bn+30% support contractgrowth; Entroacquisition contribution not separated. 2. Q2revenue308.813m+17%,GAAPGM66.5vs67.3%,adjustedopmargin20.3vs20.4%; GAAPoplosswidens58.958m. 3. FCF37.409m falls18.60%, SBC68.321m=22.12%revenue; FCFlessSBC-30.912m sensitivity is economicdilutionproxy, notactualcashburn. H1improvement heavilyconfounded by priorIPO/interest/advisorycash. Conclusion AI/ARRnot demonstrated acceleration in per-share cash. Strongestcounterargument subscriptionmix improves futureconversion andSaaSnetnewARR dominant; monitor rather thaninfer stockpayoff. FYrevenue1265–1275m, adjustedop239–244m; acquisition-adjustedreturn unverified. Allocation0. Primary: https://investor.sailpoint.com/static-files/b83fe64e-3bb0-41aa-aa9a-acf0940242e4

Sep9 premarket review; issuer-source facts separated from derived arithmetic and inference. 1. Q2sales+3%,comps-.4%,327storesvs306: reportedgrowthdoesnot prove same-store recovery; mid-single-digit newstorecomps are not cohortROIC. 2. EPSguide+$.10 while netincomeunchanged andsharecount66→64.5m; mechanical capitalstructure contribution matters. 3. Marginguide+100bp andFCFguide+50m positive, but Q2OCFincludes tariffrefunds andH172.224m remittance sits infinancing. H1adjustedFCF237.558 lessremittance165.334m is cashclassification sensitivity, not recurring normalization; exactQ2bridgepending10Q. 4.Inventory+4.4% butperstore dollars-2.3/units-5.6% reconciles footprint growth. Conclusion cash evidence improves but sourceandper-sharebridgesprevent treating headlineEPSasorganic acceleration. Counterexample customertraffic andnewbrands could improve futurecash; require cohortpayback andcostedindependentstockrule. No post-release purchase. Primary: https://www.sec.gov/Archives/edgar/data/1817358/000181735826000146/exhibit991pressreleaseq220.htm

Sep9 premarket review; issuer-source facts separated from derived arithmetic and inference. 1. Q2 organic sales +5.7% trails reported7.3%; customers+3.8% and Autoship+9.3% support demand. 2. EBITDAmargin6.8% improves YoY5.9%, but Q1 derived7.54% was higher; Q1baseline73 sales3357.2,GM30.1%,customers21.497,Autoship84.4%,FCF70.8. Q2GM30.4% includes~30bp tariff/rebate benefits and prior also had nonrecurringvendorbenefits. 3. Q2FCF89.5m improves sequentially but falls15.49%YoY ascapex+71.07%; H1FCF+3.7% despite larger adjustedprofitgrowth. Acquisitioncash552.8m andrepurchases400m need financing bridge. Conclusion mixed operatingimprovement, no newpre-evententry afterrelease. Strongest counterargument recurringAutoship/ads could accelerate futuremargin; that raisesresearchpriority, not odds from failedtest38. Guidance raise asserted byCEO inSECexhibit but exact revisedranges/call details unverified; retain next-run check. Dollar values USDm; no valuation target justified. Primary: https://www.sec.gov/Archives/edgar/data/1766502/000162828026061018/chwy-20260802.htm

Startcash49.14, no own holdings orqueuedorders perqueriedledger; goalrepeatablepre-event gains. Bindingconstraint credible netactual-windowedge, not equity or month-endshortfall. Premises1 primarycalendar1691–93 verifies17domestic earnings rows acrossSep9/10 plusInditex alreadyreleased, clinicalTYRA/IRD andTLXSep11riskboundary; calltimesarenotfirstnews. 2 LOVE final-session timeonly1676positive14.87%N10 butCIcrosses0, concentration1681 andrequiredexits1677-0.3685%/stress-2.3414%;2ADR1678+.28%stressstilluncertain. Notfreshindependentholdout afterissuer/periodselection.3 Technical1686,indicators1687,MC1682 cannotfixfailedgates. Kellyunitcorrection1685supersedes earliercashinterpretation; adoptedsize0. 4 Fundamental1638 InditexCFimprovesbutWCandleasebridge matter; pre-eventwindowalreadypast. Consequences1689keep conditionalbeneficiaries separatefrompriceedge. Own3losses includetwooperator-censoredhorizons, no observedwinner. Strongcounterargumentpositivecash/time-onlyreturns deservesnewresearch, notdeleteoutlierortradeunstopped. ConclusionnoPROPOSE/EXIT/ADJUST/FUND, no live stopsneeded. What changesmind: independent notice-aware actual-window coststressededge withpositive lowerconfidencebound, executablequotes andcash/risklimits; currentbeat/strongtape/shortfallalone insufficient. Monitor19resolved;126SAIL/CNM/KFY12:30armed,CHWY12/ASO32andothersretained. Fivejobcapblockednewcollector; tested80→132preservescoverage,actual08:15:56exit0/full1569bytefooter, next12:15:44before12:30. NewcombinedSep10nativealertrejected20cap, journalhandoffretained; aftermorning126resolvedarm successor. Sources: https://investor.lovesac.com/news-events/press-releases/detail/166/the-lovesac-company-announces-second-quarter-conference ; https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all ; Inditexprimary in1638; fullcalendarprimaryURLs1691–93 and local /tmp/codex-run-F7wXOo/preopen-plan.md. Sourceauditcut at12minallowance: DSGX/small-namecompleteness,exactDOLclaimsnextrelease,fullFDAfirstnewstiming/quotehistory remainnamedgaps. Mainworkfinished~15min, last5reservedforrecords/report; finish~20minunder42planned/45hard. Lessons513–515 saved.

Premises1 no new primary-confirmed Sep9/10 PDUFA decision found in bounded search; not a claim none exist. TLX Pixclara Sep11 goal may produce early news: https://telixpharma.com/news-views/fda-accepts-nda-for-tlx101-px-pixclara/ ; latest RSSSep1, no current entry. TYRA Sep9 08ET SURF302 clinical call https://tyrabio.investorroom.com/2026-09-04-Tyra-Biosciences-to-Host-Conference-Call-on-Initial-Results-of-Oral-Dabogratinib-from-the-SURF302-Phase-2-Study-for-IR-NMIBC-on-September-9%2C-2026 andIRD Sep9 08ET OPGx-BEST1 call https://ir.opusgtx.com/press-releases/detail/542/opus-genetics-to-present-opgx-best1-cohort-1-clinical-data-in-investor-webcast-and-at-upcoming-leading-ophthalmology-conferences are not approval deadlines or guaranteed first-news times; quant47/48 alreadycover, no cross-fund resolution. Positive full-population safety/efficacy -> record and require validated strategy; adverse/absent -> cash/reverify. 2 BLS https://www.bls.gov/schedule/2026/home.htm Sep9 10ET JuneECEC, Sep10 08:30ET AugustPPI; CPI Sep11. Census https://www.census.gov/economic-indicators/calendar-listview.html Sep9 10ET Q2services andSep10 10ET Julywholesale. EIA https://www.eia.gov/outlooks/steo/outlook.php SeptemberSTEO dateSep9, hourunknown; https://www.eia.gov/petroleum/supply/weekly/schedule.php weeklypetroleumSep10 noonET dueholiday. ECB https://www.ecb.europa.eu/press/calendars/weekly/html/index.fr.html Sep10decision14:15CET/press14:45CET asprinted; keep timezone label explicit rather than assumeUTC conversion. Joblessclaims exactnext-release agencycalendar notconfirmed; currentDOLpdfSep3 isnotSep10confirmation. 3 Benign costs/strong activity improve prospective context; adverse mix weakens it; neither proves stock returnedge. FDA townhalls/comment deadlines are not product decisions. ExistingcryptoArcSep16 outsidewindow, no separate qualified crypto catalyst established. Research scope spans issuers/sectors/Europe; no venue/FX assumptions or new fund proposal. Calendar thread cut at allowance with DSGX/small-name coverage and agencyclaims gaps named.

Premise1 call times are distinct from first news; exact release minutes are unverified unless stated. Premise2 no independently validated new actual-window edge, so no automatic purchases in either outcome branch. All rows rechecked Sep9~08UTC; ASO direct403 retains prior verified source and explicit gap. Source rows: LOVE: Before open; call08:30ET. Issuer 2026-08-27. https://investor.lovesac.com/news-events/press-releases/detail/166/the-lovesac-company-announces-second-quarter-conference MCFT: Before open; call08:30ET; overrides aggregator after-close error. Issuer 2026-08-24. https://investors.mcbh.com/news/news-details/2026/MasterCraft-Boat-Holdings-Inc--to-Webcast-Fiscal-Fourth-Quarter-and-Full-Year-2026-Earnings-Conference-Call-Thursday-September-10-2026/default.aspx CAL: Before open; call10:00ET. Issuer 2026-08-19. https://investor.caleres.com/news/news-details/2026/Caleres-to-Announce-Second-Quarter-2026-Results-on-September-10/default.aspx M: Call08:00ET; announcement gives date but not exact release minute. Issuer 2026-08-19. https://www.macysinc.com/newsroom/news/news-details/2026/Macys-Inc--to-Report-Second-Quarter-2026-Results-on-September-10-2026/default.aspx CPRT: After16:00ET; call17:30ET. Issuer 2026-09-01. https://www.copart.com/content/us/en/press-releases/copart-to-release-fourth-quarter-2026-results ORCL: After close; call16:00Central. Issuer 2026-09-02. https://investor.oracle.com/investor-news/news-details/2026/Oracle-Sets-the-Date-for-its-First-Quarter-Fiscal-Year-2027-Earnings-Announcement/default.aspx ADBE: Call14:00Pacific; exact first release minute unverified. Issuer retrieved2026-09-09. https://www.adobe.com/investor-relations.html ZUMZ: After close; call17:00ET. Issuer 2026-08-27. https://www.globenewswire.com/news-release/2026/08/27/3352391/0/en/zumiez-inc-to-report-fiscal-2026-second-quarter-results.html If operating demand, margins and cash improve: record prospective evidence and require independent costed validation. If deterioration, early announcement, rescheduling or absent results: retain cash, verify issuer and preserve failure observations. Flat book; no stops needed. This is a bounded verified watchlist, not an exhaustive whole-market calendar. Smaller unverified aggregator names and DSGX primary-date gap remain; no guessed dates. Morning monitor126 complementsCHWY12/ASO32; later new dates in handoff notes where20monitor cap binds.

Premise1 call times are distinct from first news; exact release minutes are unverified unless stated. Premise2 no independently validated new actual-window edge, so no automatic purchases in either outcome branch. All rows rechecked Sep9~08UTC; ASO direct403 retains prior verified source and explicit gap. Source rows: CHWY: Before open; call08:00ET. Issuer 2026-08-19. https://investor.chewy.com/news-and-events/news/news-details/2026/Chewy-Announces-Fiscal-Second-Quarter-Financial-Results-Conference-Call/default.aspx ASO: Before open; call10:00ET; prior primary confirmation, direct recheck403. Issuer 2026-08-26. https://investors.academy.com/news-releases/news-release-details/academy-sports-outdoors-announces-second-quarter-fiscal-2026 SAIL: Before open; call08:30ET. Issuer 2026-08-13. https://investor.sailpoint.com/news-releases/news-release-details/sailpoint-announces-date-fiscal-second-quarter-2027-earnings CNM: Before open; call08:30ET. Issuer 2026-08-26. https://coreandmain.com/news/core-and-main-to-announce-fiscal-2026-second-quarter-results/ KFY: Before open; call12:00ET. Issuer 2026-09-02. https://www.kornferry.com/about-us/press/korn-ferry-to-report-quarterly-earnings-via-live-webcast-on-september-9-2026 SIG: Primary event page confirms08:30ET call; first release time not reverified. Issuer retrieved2026-09-09. https://www.signetjewelers.com/investors/presentations-and-events/event-details/ AVAV: After close; call16:30ET. Issuer 2026-08-26. https://www.avinc.com/2026/08/26/aerovironment-inc-to-announce-first-quarter-of-fiscal-year-2027-earnings-and-host-conference-call/ NAVN: After close; call17:00ET. Issuer 2026-08-26. https://investors.navan.com/node/8791/pdf WLTH: Call17:00ET; exact first release time not reverified. Issuer 2026-08-19. https://ir.wealthfront.com/ If operating demand, margins and cash improve: record prospective evidence and require independent costed validation. If deterioration, early announcement, rescheduling or absent results: retain cash, verify issuer and preserve failure observations. Flat book; no stops needed. This is a bounded verified watchlist, not an exhaustive whole-market calendar. Smaller unverified aggregator names and DSGX primary-date gap remain; no guessed dates. Morning monitor126 complementsCHWY12/ASO32; later new dates in handoff notes where20monitor cap binds.

Premises1 Inditex H1 demand/sales and cash improved but workingcapital outflow reduced783m andinventory grew9.319%, so earnings alone do not identify repeatable cash. Source https://www.inditex.com/itxcomweb/api/media/cca26fd1-a685-41d6-82d4-10b3f30428f4/1H2026Results.pdf?t=1788937488685 . Premise2 existing LOVE1104 June11 source https://investor.lovesac.com/news-events/press-releases/detail/164/the-lovesac-company-reports-first-quarter-fiscal-2027 hasQ2EBITDAguide-4to+2m including3.6mrefund expectedrecognition; future result needs recurring margin/cash bridge, not headline comparison alone. First order (conditional): firm sell-through and controlled markdowns support retained grossprofit; tariffs/freight or promotions can absorb it. Second order: inventory, supplier payment timing and lease/capex commitments determine how much converts to distributable cash; suppliers or landlords may capture gains. Third order: durable cash can fund investment/buybacks and alter competitive position, but the stock may already price it, so positive fundamentals need not produce a positive pre-event entry. Who benefits: shareholders only if incremental cash remains after obligations; customers from value offers, suppliers from paid volumes. Strongest counterargument Inditex demonstrates cash can improve despite difficult conditions; reject uniform retail bearishness. Facts end at issuer period disclosures; no causal supplier estimate or forecasted payoff. Upcoming M/CAL/MCFT/ZUMZ have distinct businesses; do not transfer LOVEodds mechanically. No extra fund proposal.

Ran required CLI: node /app/agent/dist/backtest.js --symbols LOVE --strategy momentum --lookback 20 --days 730 --stop-pct 5 --target-pct 10 . It returns501dailybars,56trades,return-17.85047%,DD44.98827%,win32.14286%,meantrade-.164327%,buyhold-22.94455%. Premise1 this generic unsplit no-fee momentum rule is not an earnings-specific holdout. Premise2 negative gross diagnostics cannot validate current allocation. Conclusion do not trust screen; actual selected chronological event experiment1676–78 uses fees/slippage, full15min marks and independent reconciliation. FirstCLIoutput was display-truncated, exact rerun saved love_cli.json to verify N56; numerical totals unchanged. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE&timeframe=1Day&feed=iex .

Premises1 primary event still pending, exact tested entry window, independent positive costed expectancy, executable risk and capital constraints must all pass. 2 LOVE final-session diagnostics: trendpositiveN6 mean.026658%, momentumpositiveN5 mean.019224%, markettrendpositiveN7 mean-.219100%; opposite groups positive but selected tiny samples, not an optimized filter. Current SPY765.96>SMA50 757.5966 whileLOVE belowSMA50 and20momentumnegative. This combination is not an independently validated conditional edge. All6fixedgroup figures observations18337–18342. 3 TLX/CPRT stronger tape cannot repair FDA first-news risk or a failed/missed earnings window. 4 Time-only LOVE meanCI crosseszero and fixed mandatory exits deteriorate; therefore no PROPOSE even though whole shares affordable. Strongcounterexample future independent event cohort could establish positive expectancy; do not infer all run-ups fail. No new parameter search. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all and daily panels18292–18299; primary upcoming source https://investor.lovesac.com/news-events/press-releases/detail/166/the-lovesac-company-announces-second-quarter-conference .

Premise1 completed Sep8 SIP adjusted bars,89each: LOVE16.07 belowSMA20 16.47025/SMA50 16.9366,20session-7.10983%,ADR20.655065 and simpleATR14.693036. MCFT23.53/M22.45/CAL12.03/ZUMZ17.70 all below20/50SMA withnegative20momentum; wholecapacity2/2/4/2 respectively beforefees at49.14fundcap. These are context, not a profitable bearish or mean-reversion signal. Premise2 LOVE one-range stop anchored hypothetically at Sep8close would be15.414935 and1.5range target17.052598; this is a paper geometry, not live order levels or executable entry. Actual entry changes levels; marginal costs reduce gross1.5reward/risk. The matching mandated-exit study1677 loses0.3685%,stress2.3414% over10events. Stop checks15min, not guaranteed touches. Premise3 CPRT32.60 is stronger,+10.1724%20sessions, but prior actual T3 rule113 was rejected and its entry window elapsed. TLX11.98 is above20/50SMA but Sep11 deadline does not protect Sep9/10 from early decision or other pipeline news. No overnight biotech proposal. All observations18292–18299 includevolume/ranges/means and source. Nominal1%equityrisk8.5099/fund49.14/maxvenue212.7475 are ceilings, not reason to deploy. Source https://runway.adityaperswal.workers.dev/data/stock-bars?timeframe=1Day&feed=sip&adjustment=all . No current bidask or limit fill assumed; no live stops to adjust while flat.